OTTAWA, Ontario--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration ...

OTTAWA, Ontario--(BUSINESS WIRE)--Life-saving Molybdenum-99 (Mo-99) isotopes can now be produced at Ontario Power Generation’s (OPG) Darlington Nuclear Generating Station, thanks to the installation ...

BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration (FDA) to request approval of its ...

本研究优化了Tc-99m标记抗生素（头孢克肟、头孢曲松、环丙沙星）的制备工艺，通过扫描电镜、ITLC、傅里叶变换红外光谱及HPLC验证标记纯度与稳定性，并以小鼠SPECT显像评估其感染定位和诊断潜力，结果显示标记效率达96.8%，具有显著感染特异性，为感染影像 ...

The Food and Drug Administration recently announced approval of the RadioGenix™ System, a technetium 99m (Tc-99m) generator. The RadioGenix™ System is developed by NorthStar Medical Radioisotopes, LLC ...

The Australian Nuclear Science and Technology Organisation expects to be able to recommence production of technetium-99m generators this week, following repair to a conveyer belt. ANSTO's new ...

LYNCHBURG, Va.--(BUSINESS WIRE)-- BWX Technologies, Inc. (NYSE: BWXT) announced today that it has successfully labeled technetium-99m (Tc-99m) derived from its proprietary molybdenum-99 (Mo-99) ...

Tackling supply shortages: As the supply chain for medical radioisotopes continues to struggle, researchers are developing new methods for producing technetium-99m, and exploring the potential of ...

本研究针对肾肿瘤术前鉴别良恶性的临床难题，开展了多中心前瞻性诊断试验MULTI-MIBI，验证[99mTc]Tc-sestamibi SPECT/CT对T1期肾肿瘤 ...